Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariola Sadowska

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Integrative Cancer Therapies|May 29, 2014
A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myelomaTing Bao, Olga Goloubeva, Colleen Pelser, et al.
Journal of Virology|February 1, 2005
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virusMahmoud Djavani, Ivan Topisirovic, Juan Carlos Zapata, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemiaIvana Gojo, Ming Tan, Hong-Bin Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancerKenneth H Yu, Mark Ricigliano, Manuel Hidalgo, et al.
Cancer Chemotherapy and Pharmacology|August 17, 2013
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Mariola Sadowska, Alison Walker, et al.
Plos Genetics|February 6, 2014
Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma developmentKrystyna Mazan-Mamczarz, X Frank Zhao, Bojie Dai, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2016
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Rena G Lapidus, Brandon A Carter-Cooper, Mariola Sadowska, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Integrative Cancer Therapies|May 29, 2014
A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myelomaTing Bao, Olga Goloubeva, Colleen Pelser, et al.
Journal of Virology|February 1, 2005
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virusMahmoud Djavani, Ivan Topisirovic, Juan Carlos Zapata, et al.
ACS Medicinal Chemistry Letters|May 17, 2011
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring SystemAtul Kondaskar, Shilpi Kondaskar, Raj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemiaIvana Gojo, Ming Tan, Hong-Bin Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancerKenneth H Yu, Mark Ricigliano, Manuel Hidalgo, et al.
Cancer Chemotherapy and Pharmacology|August 17, 2013
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemiasIvana Gojo, Mariola Sadowska, Alison Walker, et al.
Plos Genetics|February 6, 2014
Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma developmentKrystyna Mazan-Mamczarz, X Frank Zhao, Bojie Dai, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2016
Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Rena G Lapidus, Brandon A Carter-Cooper, Mariola Sadowska, et al.
Pageof 2